Attached files
| file | filename |
|---|---|
| S-1 - Talon Therapeutics, Inc. | v220634_s-1.htm |
| EX-5.1 - Talon Therapeutics, Inc. | v220634_ex5-1.htm |
| EX-10.31 - Talon Therapeutics, Inc. | v220634_ex10-31.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Talon Therapeutics, Inc.
San Mateo, California
We hereby consent to the use in the Prospectus constituting a part of this Registration Statement of our report dated March 28, 2011, relating to the financial statements of Talon Therapeutics, Inc., which is contained in that Prospectus. Our report contains an explanatory paragraph regarding the Company’s ability to continue as a going concern.
We also consent to the reference to us under the caption “Experts” in the Prospectus.
BDO USA, LLP
San Jose, California
May 5, 2011